Skip to content

Assessment and pharmacotherapy for mental state in children considering biochemical examination.

Assessment and pharmacotherapy for mental state in children considering biochemical examination. - APMSC Study

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031240317
Enrollment
42
Registered
2024-09-04
Start date
2024-09-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with decreased serum ferritin levels

Interventions

Patients with decreased serum ferritin levels (<30 ng/mL) are given iron orally.

Sponsors

Yuki Takahashi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients visiting the outpatient psychiatry department of Tokai University Hospital or Aikou Hospital. 2. Age between 6 and 12 years old. 3. Ease of fatigue (moderate or severe on the Japanese version of the Brief Fatigue Inventory) or insomnia (42 or more points on the Japanese version of the Children's Sleep Habits Questionnaire (CSHQ-J)) 4. Serum ferritin level less than 30 ng/mL. 5. Patients who have received a full explanation of their participation in this study and have obtained written consent from the research subjects and their guardians.

Exclusion criteria

Exclusion criteria: 1. those taking psychotropic drugs (antipsychotics and antidepressants, anxiolytics, sleep medications, antiepileptic drugs) or steroids 2. have an active malignancy or known infectious, autoimmune, or inflammatory disease 3. Hb less than 12 g/dl 4. other patients who are deemed inappropriate by the physician in charge.

Design outcomes

Primary

MeasureTime frame
1. CGI-I: 4-9 weeks,12 weeks,24 weeks 2. CSHQ-J: before drug administration,12 weeks,24 weeks 3. Japanese version of Brief Fatigue Inventory: before drug administration,12 weeks,24 weeks

Secondary

MeasureTime frame
1. Hematology (Hb, MCV): Baseline (0 week),12 wee ks (including 3 weeks before and after),24 weeks (including 3 weeks before and after) 2. Hematology (Fe, TIBC, ferritin): Baseline (0 week),12 weeks (including 3 weeks before and after ), 24 weeks (including 3 weeks before and after) 3. QCD:4-9 weeks,12 weeks,24 weeks 4. CGI-S: before drug administration, 4-9 weeks,12 weeks,24 weeks 5. POMS2: before drug administration,12 weeks,24 weeks

Contacts

Public ContactTakahashi Yuki

Tokai University Hospital

y-takahashi@tokai.ac.jp+81-463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026